Discover HKBU

Using Chinese medicine to help people with "long COVID"

7 Sep 2022

20220907_1 20220907_1
(From left) Professor Bian Zhaoxiang, Associate Vice-President (Chinese Medicine Development) and Director of the Clinical Division of the School of Chinese Medicine; Professor Alexander Wai, President and Vice-Chancellor; Dr Bunny Chan Chung-bun, Chief Convenor of the Hong Kong Community Anti-Coronavirus Link; and Mr Liu Jia, Vice President of China Everbright Holdings Co Ltd announce the launch of the “Everbright Care • Long COVID Chinese Medicine Rehabilitation Programme”.

 

A large proportion of people who catch COVID-19 report long-term chronic health issues after infection, but the new “Everbright Care • Long COVID Chinese Medicine Rehabilitation Programme” launched by the School of Chinese Medicine aims to help those with the condition.

Under the programme, HKBU Chinese medicine practitioners will provide a free “long COVID” consultation service and Chinese medicine to people who were hospitalised due to the virus and have since recovered, and recovered elderly people aged 65 or above.

The programme is supported by a generous donation of HK$5 million from the Hong Kong Community Anti-Coronavirus Link. The funding will be allocated from the donation made by the Hong Kong office of the Everbright Group to the Link designated for the purpose of fighting COVID-19.

Online registration for the programme began on 7 September. Based on the clinical symptoms and body constitutions of the participants, HKBU Chinese medicine practitioners will provide up to four sessions of free Chinese medicine consultations. A maximum of six days of Chinese medicine granules will be prescribed for participants in each consultation session, depending on their actual condition.

Professor Bian Zhaoxiang, Associate Vice-President (Chinese Medicine Development) and Director of the Clinical Division of the School of Chinese Medicine, said: “Chinese medicine’s contribution to treating COVID-19 has been recognised by the community, and we have accumulated valuable experience. Many recovered patients have ‘long COVID’ symptoms such as a cough, shortness of breath, insomnia, hair loss, skin irritation, and fatigue. Chinese medicine has rich experience in treating these symptoms effectively. Through this programme, we hope to further strengthen the role of Chinese medicine in the fight against the pandemic, and relieve the issues encountered by recovering patients, thus improving their quality of life.”

Dr Bunny Chan Chung-bun, Chief Convenor of the Hong Kong Community Anti-Coronavirus Link, said: “The Hong Kong Community Anti-Coronavirus Link promotes the spirit of joining hands to fight against COVID-19 in the community, and it is committed to uniting different sectors of society to combat the disease. As HKBU spares no effort to help society fight against COVID-19, we are supporting the University to launch the ‘Everbright Care • Long COVID Chinese Medicine Rehabilitation Programme’ to offer special care to elderly people and those who have been hospitalised due to the disease, so that more comprehensive and precise support can be provided to people for their COVID-19 rehabilitation.”

Mr Liu Jia, Vice President of China Everbright Holdings Co Ltd, said: “Founded in Hong Kong in 1983, the Everbright Group has long been rooted in the city, and it has heartily contributed to its ongoing development and prosperity. The ‘Everbright Care • Long COVID Chinese Medicine Rehabilitation Programme’ will offer free consultations and medication services to a designated group of people. We believe this programme will further leverage the positive impacts of Chinese medicine in the fight against the pandemic, and support the Hong Kong community to robustly overcome the challenges of the pandemic.”

Please click here for further details of the programme.